Latest filing published 13 May 2026 for Rein Therapeutics, Inc., €21k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James Brian Windsor is a declared insider of Rein Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 20 November 2023 to 30 April 2026.
On the market, this insider has only ever bought: 4 purchases, €32k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 option exercise. 2026 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €4,923. No cluster: in 4 purchases, no other insider of the company bought within 30 days.
The record was last updated on 13 May 2026 with an open-market purchase (€21k) in Rein Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations